Demo highlighted enhanced geo-targeting capabilities, infotainment, and real-time emergency information HUNT VALLEY, Md.–(BUSINESS WIRE)–Sinclair Broadcast…
Names Natalie Marjancik as Partner Promotes James Shovlin, David Meyers and Jordan Fong Expands Kate…
Transitional, Bridge and Event Driven, and Stable Cash Flow platforms enable 3650 to accommodate wider…
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE:LTC) announced today that it had declared a monthly…
BETHESDA, Md.–(BUSINESS WIRE)–Fidelis Cybersecurity, a portfolio company of Skyview Capital, today announced its platforms have…
Seamless scalability via the flexible reactor facilitates significant time savings throughout development stage up to…
12th Annual Corporate Access Event Register for in-person meetings with Lumos Pharma AUSTIN, Texas, Jan….
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
REDWOOD CITY, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) — Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company…
SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology…
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend that AVEO Stockholders Vote “FOR”…
WOBURN, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical…
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
Cell Therapy Veteran and Former Kite Pharma Clinical Leader to Head Development of Expanding Portfolio…
FDA Fast-Track designation was granted to investigate abelacimab for the prevention of stroke and systemic…
All three sickle cell disease participants treated with briquilimab successfully engrafted with neutrophil engraftment within…
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
MHRA denies Oral Paclitaxel for metastatic breast cancer based solely on chemistry, manufacturing and control…
COPENHAGEN, Denmark, Jan. 03, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) announced today…
WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company…